|Day Low/High||43.83 / 45.53|
|52 Wk Low/High||40.52 / 64.50|
These names are showing both technical and quantitative deterioration.
With so many consumers preparing for a potential coronavirus outbreak, you might think that owning retail pharmacy stocks makes sense right now.
I just saw that Sky News is reporting that KKR may be lining up to make an $8 billion bid on Coty's hair care business, that includes Wella, Clairol and Good Hair Day. If true, it's a potentially interesting fit given that KKR has been linked to the...
RMPIA ended January up 0.8%, but now the damage from the Wuhan virus is weighing on the future.
While both companies appear like winners, WBA should have more to gain because of its discounted price.
The NYSE used to be the center of capitalism, but now it's where actual engineering, not financial engineering, is taking place.
Here's how two big events early this week make me view this name that's one of my favorite undervalued, dividend-paying companies.
Apparently, unless the Iranian military simply does not train on their weapons, which I do not believe, the exercise was one of saving face... for now.
The upcoming quarterly report for WBA might be a market mover, but the charts and indicators of CVS show a healthy stock ready to rise.
Let's review 2019 performance of RMPIA in relation to stock indexes and see what's ahead.
Watch for analysts and strategists to turn into armageddonists forgetting that China's the real issue.
Also: People's Bank of China, the Fed, U.S./China trade deal, Brexit, USMCA.
Wrong valuations -- such as those in Conagra Brands and Rite Aid -- exist, and they can make you money.
Stocks of GE and Walgreens Boots Alliance are examples of 'Dogs of the Dow' that could surprise on the upside.
I see upside back to above $70 regardless of whether the company gets taken private.
Plus, a glance at news about Disney+, Boeing's 737 Max and Alphabet's "Project Nightingale."
Everywhere I go I hear the smart money is betting on a recession, that earnings will be down, but every day something contradicts these bears.
At some point the market's inconsistency will resolve itself either way.
I'm all in favor of mergers and acquisitions -- the more we get, the higher the stock market goes -- but I am not in favor of making conclusions based on tips about deals.
Reports of two potentially major buyouts show the risks of late-cycle corporate bond investing.
The RMPIA's 3.8% jump even beat the Nasdaq Composite Index's 3.7% October climb.
The odds of a Fed December rate cut are now very low. I think the marketplace handles that just fine, as long as the statement with this week's expected cut does not sound too tough, or too cautious.
Rest up for a busy week that includes earnings from Apple, Facebook and Starbucks.
RMPIA is up 20.9% in the first nine months of 2019.
In July, the RMPIA climbed 0.6%, bringing its year-to-date return to just over 21%.
We suspect the new short-term uptrend has some degree of validity
There are a number of RMPIA companies that will be beneficiaries of Back to School and holiday spending.